Osteoporosis Drugs and Dementia Risk: What to Know

A study of 121,492 adults aged 60 and older, covered by ScienceDaily and other outlets in early November 2026, found that people taking nitrogen-containing bisphosphonates had a lower rate of Alzheimer's and related dementias. These are alendronate, risedronate, ibandronate and zoledronate. The reported risk was 16% lower than in people taking no osteoporosis drug, and 24% lower than in people taking other osteoporosis drugs. The finding is observational, so it can't show that the drugs prevent dementia. This post follows an ordinary day to show where osteoporosis drugs and dementia risk questions fit into your routine, and one point applies from the first minute: nobody should start or stop a bone drug because of this study.

Morning: Taking Your Pill the Way It Was Prescribed

If you take an oral bisphosphonate, mornings are probably when you take it. Alendronate and risedronate are typically taken first thing, on an empty stomach, with a full glass of plain water, and you stay upright for at least 30 minutes before eating. Ibandronate comes as a monthly pill or a periodic injection. The monthly pill has a longer wait: stay upright and have nothing but plain water for at least 60 minutes after taking it. Zoledronate is given as an infusion, often once a year. Check your own label or ask your pharmacist about the exact rules for your drug, because they differ.

Nothing in the new study changes those instructions. Taking the drug correctly is what protects your bones, and that is the reason it was prescribed.

Mid-Morning: What the Study Found and Didn't Prove

The 121,492-person study is a population-based study in Hong Kong, published in Alzheimer's & Dementia in July 2025. It followed adults 60 and older with osteoporosis or a fragility fracture from 2005 to 2020, comparing people who took nitrogen-containing bisphosphonates with matched people who took no osteoporosis drug or a different one. It is observational, meaning researchers looked at records of what people took and what happened later.

That design has limits. People who are prescribed a bone drug may differ from those who aren't in ways records don't capture, such as how often they see a doctor, how active they are, or how they eat. Researchers try to adjust for these differences, but they can't remove all of them. A 16% lower risk is a signal worth testing in a randomized trial. It is not a reason to treat bisphosphonates as a dementia medicine.

Late Morning: If You Already Take a Bone Drug

Keep taking it as prescribed. Your clinician chose it to lower your chance of a fracture, and that benefit is established. The dementia finding is a possible bonus that needs more research.

If you have questions about how long you've been on the drug, bring them to your next appointment instead of deciding alone. Treatment length is a real conversation, since some people take a break from bisphosphonates after several years depending on their fracture risk. That decision belongs with your clinician, and it rests on your bone health, not on this study.

The same applies if you are caring for a parent who takes one. Don't change their medicine because of a headline. Write down any worries and raise them with their prescriber or pharmacist.

Midday: Why Treating Osteoporosis Already Matters

Osteoporosis often causes no symptoms until a bone breaks. Hip and spine fractures can lead to lasting pain, loss of independence and a long recovery. The Bone Health and Osteoporosis Foundation's clinician's guide to osteoporosis prevention and treatment advises doctors on who to screen and who to treat, and it lists bisphosphonates among the medication options for people at high fracture risk.

That is the evidence that should guide decisions about these drugs. They are used to prevent fractures, and they have been studied for that purpose for years. Any brain benefit would be an extra, and it is unproven.

Afternoon: Bone Density Screening Questions to Ask

If you've never had a bone density scan, or it's been a while, this is a good time to ask about one. The US Preventive Services Task Force recommends screening for women 65 and older, and for postmenopausal women under 65 who are at increased risk. Men aren't covered by that recommendation, but a clinician may still suggest a scan if you have risk factors such as a past fracture, long-term steroid use, or a family history of hip fracture.

Questions to bring to your appointment:

  • Am I due for a bone density scan, and how often should I repeat it?
  • What is my fracture risk over the next 10 years?
  • Do any of my current medicines or health conditions affect my bones?
  • If I need treatment, which options fit me, and what are their side effects?
  • If I already take a bone drug, how long should I stay on it?

Mention your dementia concerns too, especially if there is a family history. Your clinician can talk about brain health separately from bone treatment.

Evening: Tracking Your Routine

Evening is a good time to look back at the day. Did you take your bone drug on schedule? Did you have heartburn, new thigh or jaw pain, or any near-falls? SteadiDay's Daily check-ins, which are on the free plan, give you a place to note these things so you have specifics when you see your clinician. Write down any dose you missed too, since a pattern is easier to spot on paper than in memory.

Before bed, spend a few minutes on fall prevention: clear walkways, working night lights, and sturdy footwear for nighttime bathroom trips. Preventing a fall protects your bones whether or not you take a drug.

Common Questions

Do bisphosphonates prevent dementia?

No one knows yet. A study of 121,492 adults found a 16% lower dementia risk compared with no osteoporosis drug, but it was observational and can't show cause and effect. Only randomized trials could answer that question.

Should I start taking a bisphosphonate to lower my dementia risk?

No. These drugs are prescribed to lower fracture risk, and they carry side effects and eligibility criteria. Ask your clinician about bone density screening, and let your bone health, not this study, guide any decision to start treatment.

Should I stop my osteoporosis medicine if I'm worried about the news?

Don't stop it on your own. Stopping can leave your bones less protected. If you have concerns about side effects or how long you've been on it, talk with your prescriber, who can review your fracture risk.

Who should get a bone density scan?

The US Preventive Services Task Force recommends screening for women 65 and older, and for postmenopausal women under 65 at increased risk. Men and others with risk factors, such as a prior fracture or long-term steroid use, can ask a clinician whether a scan makes sense.

Updated November 15, 2026: We added the 60-minute rule for monthly ibandronate pills and confirmed that the Hong Kong study we cite is the same 121,492-person study covered in the news.

Sources

This article draws on the sources below. Each entry shows the passage it supports.

  1. Alzheimer's & Dementia: “population-based study in Hong Kong”
  2. PubMed: “clinician's guide to osteoporosis prevention and treatment”
  3. US Preventive Services Task Force: “US Preventive Services Task Force”

SteadiDay for iPhone

Emergency SOS, fall detection and medication reminders are free, with no card to enter. Premium adds Share Activity for caregivers, Apple Health and the wellness tools.

Download on the App Store
← See all blog posts